Education
About Us
Working with TipRanks
Follow Us
LSL Pharma Group Inc (TSE:LSL)
:LSL
LSL Stock Chart & Stats
C$0.36
--
Market closed
C$0.36
--
Day’s Range― - ―
52-Week RangeC$0.29 - C$0.53
Previous CloseN/A
VolumeN/A
Average Volume (3M)69.99K
Market Cap
C$43.64M
Enterprise ValueC$69.34M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)14.5
Beta0.75
Next Earnings
May 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding121,220,180
10 Day Avg. Volume70,510
30 Day Avg. Volume69,989
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LSL Pharma Group Inc News
LSL FAQ
What was LSL Pharma Group Inc’s price range in the past 12 months?
LSL Pharma Group Inc lowest stock price was C$0.29 and its highest was C$0.53 in the past 12 months.
What is LSL Pharma Group Inc’s market cap?
LSL Pharma Group Inc’s market cap is C$43.64M.
When is LSL Pharma Group Inc’s upcoming earnings report date?
LSL Pharma Group Inc’s upcoming earnings report date is May 06, 2026 which is in 134 days.
How were LSL Pharma Group Inc’s earnings last quarter?
LSL Pharma Group Inc released its earnings results on Nov 19, 2025. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is LSL Pharma Group Inc overvalued?
According to Wall Street analysts LSL Pharma Group Inc’s price is currently Overvalued.
Does LSL Pharma Group Inc pay dividends?
LSL Pharma Group Inc does not currently pay dividends.
What is LSL Pharma Group Inc’s EPS estimate?
LSL Pharma Group Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LSL Pharma Group Inc have?
LSL Pharma Group Inc has 121,220,180 shares outstanding.
What happened to LSL Pharma Group Inc’s price movement after its last earnings report?
LSL Pharma Group Inc reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.882%.
Which hedge fund is a major shareholder of LSL Pharma Group Inc?
Currently, no hedge funds are holding shares in TSE:LSL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
LSL Pharma Group Inc
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.
Technical Analysis
Genix Pharmaceuticals
―
Love Pharma Inc
―
Mydecine Innovations Group
―
Lumiera Health Inc
―
NAVCO Pharmaceuticals Inc
―
Options Prices
Currently, No data available
---